8/29/2025NHSA Announces Results of Form Review for 2025 NRDL Submissions

8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...

8/27/2025China Pushes for Biopharma-Focused Investment Funds to Accelerate Sect...

8/27/2025Royalty Pharma Targets China's Biotech Market with Early-Stage Investm...

8/27/2025CRO ChemPartner to Open New Boston Research Hub in September

8/27/2025Chinese Scientist Arrested in Houston Over Alleged Theft of Breast Can...

8/27/2025Tibet Rhodiola Bets Big on Cutting-Edge Gene-Editing Pioneer AccurEdit...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

8/26/2025Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...

8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...

8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China

8/26/2025Pregene Secures Orphan Drug Status for Innovative Dual-Target CAR-T Th...

8/26/2025CorrectSequence's CS-101: A Breakthru Base-Editing Therapy Cures First...

8/26/2025Centergene's SJ02 Approved for Marketing, Advancing Assisted Reproduct...

8/26/2025InxMed Advances in Oncology with Upcoming IPO and Promising Pipeline

8/26/2025Fosun and Sitala Forge Strategic Global Partnership for FXS6837

8/25/2025Minova Secures Over ¥100M in Series B Financing Led by IDG Capital

8/25/2025Vibrant Secures Series A Financing to Advance Computational I/O Therap...

8/25/2025HemaCell Receives FDA IND Approval for Megakaryocyte Therapy

8/25/2025BeOne Nets Up to $950M in Royalty Deal for Amgen’s Lung Cancer Drug

8/25/2025Anye Pharma Completes Series A Financing to Advance Neurological Drug ...

8/25/2025Vivace Therapeutics Secures FDA Orphan Drug Designation for VT3989 in ...

8/23/2025Recent Executive Moves

8/23/2025IxCell Secures New Financing to Advance Cell Therapy Programs

8/22/2025InxMed Secures Over $34M in Series C Financing to Advance Oncology Pip...

8/22/2025Bao Pharma Advances with Hong Kong IPO amid Promising Pipeline

8/22/2025LongBio Advances with Hong Kong IPO Amidst Promising Clinical Pipeline

8/22/2025NMPA Approves AZ/Daiichi Sankyo's Datopotamab Deruxtecan

8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance

8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...

Page:19/58 Total number of articles:1737: [First][<<] [17] [18] [19] [20] [21] [>>] [End]